Benzinga··Vandana SinghCertara Divests Regulatory Unit to Veristat for $135M, Refocuses on Core Platform
Certara sells Regulatory and Medical Writing business to Veristat for $135M, refocusing on core biosimulation platform ahead of Q2 2026 closing.
SLPCERTdivestiturestrategic focus